Michael Wondrasch
Net Worth
Last updated:
What is Michael Wondrasch net worth?
The estimated net worth of Mr. Michael Wondrasch is at least $25,455,938 as of 21 May 2021. He owns shares worth $15,513,484 as insider, has earned $1,856,154 from insider trading and has received compensation worth at least $8,086,300 in Avantor, Inc. and Avantor, Inc..
What is the salary of Michael Wondrasch?
Mr. Michael Wondrasch salary is $808,630 per year as Executive Vice President & Chief Information Officer in Avantor, Inc.. He also receives $808,630 as Executive Vice President & Chief Information Officer in Avantor, Inc..
How old is Michael Wondrasch?
Mr. Michael Wondrasch is 56 years old, born in 1969.
What stocks does Michael Wondrasch currently own?
As insider, Mr. Michael Wondrasch owns shares in 2 companies:
| Company | Title | Shares | Price per share | Total value |
|---|---|---|---|---|
| Avantor, Inc. (AVTR) | Executive Vice President & Chief Information Officer | 113,295 | $12.82 | $1,452,442 |
| Avantor, Inc. (AVTR-PA) | Executive Vice President & Chief Information Officer | 113,295 | $124.11 | $14,061,042 |
What does Avantor, Inc. do?
Avantor, Inc. provides products and services to customers in biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips. It also provides equipment and instrumentation products, including filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets, and critical environment supplies. In addition, the company offers services and specialty procurements comprising onsite lab and production, clinical, equipment, procurement and sourcing, and biopharmaceutical material scale-up and development services. Avantor, Inc. was founded in 1904 and is headquartered in Radnor, Pennsylvania.
What does Avantor, Inc. do?
Avantor, Inc. provides products and services to customers in biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips. It also provides equipment and instrumentation products, including filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets, and critical environment supplies. In addition, the company offers services and specialty procurements comprising onsite lab and production, clinical, equipment, procurement and sourcing, and biopharmaceutical material scale-up and development services. Avantor, Inc. was founded in 1904 and is headquartered in Radnor, Pennsylvania.
Michael Wondrasch insider trading
Avantor, Inc.
Mr. Michael Wondrasch has made 4 insider trades between 2020-2021, according to the Form 4 filled with the SEC. Most recently he sold 18,488 units of AVTR stock on 21 May 2021.
The largest trade he's ever made was exercising 40,000 units of AVTR stock on 5 Feb 2021. As of 21 May 2021 he still owns at least 113,295 units of AVTR stock.
Avantor, Inc.
Mr. Michael Wondrasch has made 4 insider trades between 2020-2021, according to the Form 4 filled with the SEC. Most recently he sold 18,488 units of AVTR-PA stock worth $580,708 on 21 May 2021.
The largest trade he's ever made was exercising 40,000 units of AVTR-PA stock on 5 Feb 2021. As of 21 May 2021 he still owns at least 113,295 units of AVTR-PA stock.
Avantor key executives
Avantor, Inc. executives and other stock owners filed with the SEC:
- Dr. Gerald Brophy Ph.D. (59) Executive Vice President of Biopharma Production
- Mr. Frederic Vanderhaegen (58) Executive Vice President of Americas & Europe
- Mr. Michael Stubblefield (52) Pres, Chief Executive Officer & Director
- Mr. Michael Wondrasch (56) Executive Vice President & Chief Information Officer
- Mr. Thomas A. Szlosek (61) Executive Vice President & Chief Financial Officer